StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GRCE

Grace Therapeutics, Inc.

GRCE Nasdaq Pharmaceutical Preparations EDGAR ↗
$2.08
+0.01 +0.48%

Key statistics

from XBRL data in SEC filings
Market cap
Revenue (TTM)
Net income (TTM)
EPS (TTM)
P/E ratio
Dividend yield
Free cash flow
Cash
Total assets
Gross margin
52-week range
$1.79 – $5.18

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 28, 2026 8-K Other events Jun 18, 2026 8-K Results of operations (earnings release) Jun 18, 2026 10-K Fiscal year ended 2026-03-31 Jun 18, 2026 8-K Director or officer change Jun 5, 2026 8-K Other events Apr 27, 2026 8-K Other events Apr 23, 2026 8-K Results of operations (earnings release) Feb 12, 2026 10-Q Quarter ended 2025-12-31 Feb 12, 2026 8-K Director or officer change Jan 12, 2026 10-Q/A Quarter ended 2025-09-30 Nov 17, 2025 8-K Results of operations (earnings release); Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Oct 23, 2025 8-K Other events Sep 18, 2025 8-K Shareholder vote results Sep 12, 2025 8-K Other events Aug 27, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Other events Jun 25, 2025 8-K Results of operations (earnings release) Jun 23, 2025 10-K Fiscal year ended 2025-03-31 Jun 23, 2025 8-K Other events Apr 9, 2025 8-K Other events Mar 3, 2025 10-Q/A Quarter ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Feb 13, 2025 10-Q Quarter ended 2024-12-31 Feb 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Feb 10, 2025 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Amended charter or bylaws Oct 28, 2024 8-K Other events Oct 25, 2024 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Oct 7, 2024 8-K Director or officer change; Shareholder vote results Sep 30, 2024 8-K Other events Sep 25, 2024 8-K Director or officer change Aug 16, 2024 8-K Results of operations (earnings release) Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Other events Jun 27, 2024 8-K Results of operations (earnings release) Jun 21, 2024